Colorectal Neoplasms Malignant Clinical Trial
Official title:
Is Socioeconomic Position Associated With Acute Onset of Colon Cancer and 1-year Mortality After Acute Colon Cancer Surgery
Verified date | July 2018 |
Source | Zealand University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
Acute colon cancer surgery has a poor 90-day mortality of 21.0% compared with only 3% after
elective colorectal cancer surgery in Denmark. The high mortality after acute colon cancer
surgery compared with elective surgery emphasizes the importance of identifying factors
associated with acute onset and poor short-term survival after acute surgery. Socioeconomic
position has previously showed to be a risk factor for acute versus elective onset of
colorectal cancer. Furthermore, if patients with low socioeconomic position have higher
postoperative mortality this could reflect differences in the treatment of patients according
to their socioeconomic position.
The aim of the clinical study is:
1. To examine if patients with short education, low income, living alone, or living in
rural areas are more likely to undergo acute colorectal cancer surgery than elective
surgery compared with patients with longer educations, higher income, living with a
partner, or living in urban areas.
2. To examine if there is an association between education, income, cohabitation, or
urbanicity and 1-year mortality after acute colorectal cancer surgery.
Status | Active, not recruiting |
Enrollment | 35000 |
Est. completion date | July 31, 2018 |
Est. primary completion date | May 31, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: First study - All patients undergoing a surgical procedure for colorectal cancer in Denmark and registered in the Danish Colorectal Cancer Group (DCCG.dk) database from 1st of January 2007 to 31st of December 2016. If a patient dies during surgery, they will also be included. Second study - All patients operated for acute colorectal cancer in Denmark from 1st of January 2007 to 31st of December 2016 and registered in the DCCG.dk database. Acute surgery can either be colectomy, placement of self-expanding metallic stent, diverting stoma, or damage control surgery. If a patient dies during surgery, they will also be included. Exclusion criteria: Both studies: - Not registered In the DCCG.dk database with a colorectal cancer diagnose. - Missing on income, urbanicity, cohabitation, or UICC-stage. Second study: - Registered in the DCCG.dk database with an elective surgical procedure without a registration of SEMS or diverting stoma 72 hours before an emergency admission in NPR. - lost to follow-up one year postoperative. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Zealand University Hospital | Danish Cancer Society |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of acute colorectal cancer surgery (study 1) | Acute surgery as the first surgical intervention for colorectal cancer. This is registered by the surgeon in the DCCG.dk database prior to surgery. A surgical procedure is registered as acute by the surgeon based on clinical symptoms of an abdominal crises and how fast the surgical procedure is performed after onset of acute symptoms. There was no defined time limit from onset of symptoms to onset of procedure in order to classify the procedure as acute. This was up to the surgeon who registered the patient. |
At the time of surgery | |
Primary | Postoperative 1-year mortality rate (study 2) | 1-year mortality after acute colorectal cancer surgery | Within 365 days of surgery | |
Secondary | Postoperative 90-day mortality (study 2) | 90-day mortality after acute colorectal cancer surgery | Within 90-days of surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04712292 -
Effects of COVID-19 Pandemic on the Outcomes of Colorectal Cancer
|
||
Active, not recruiting |
NCT03775980 -
CIRSE Emprint Microwave Ablation Registry
|
||
Recruiting |
NCT05155124 -
Safety of Cetuximab and Trifluridin Tipiracil as the Third-line Therapy in the RASwt mCRC
|
Phase 1 | |
Recruiting |
NCT06050447 -
Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
|
||
Active, not recruiting |
NCT03993626 -
A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT06314971 -
Predicting Local and Distant Recurrence in T1 Colorectal Cancer
|
||
Recruiting |
NCT06342440 -
Early Detection of Advanced Adenomas and Colorectal Cancer
|
||
Recruiting |
NCT05853094 -
Postoperative Effects of Different Enterostomy Approaches
|
N/A | |
Recruiting |
NCT06200831 -
Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases
|
N/A | |
Recruiting |
NCT02758951 -
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
|
Phase 2/Phase 3 | |
Recruiting |
NCT03686254 -
The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM
|
Phase 2/Phase 3 | |
Recruiting |
NCT05278351 -
Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC
|
Phase 2 | |
Terminated |
NCT04873895 -
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)
|
Phase 1 | |
Completed |
NCT04002128 -
Tracheal Colonization and Outcome After Major Abdominal Cancer Surgery
|
N/A | |
Recruiting |
NCT06208371 -
Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM
|
Phase 3 | |
Not yet recruiting |
NCT05129774 -
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
|
N/A | |
Completed |
NCT06410729 -
Significance of Benign Lymph Node Enlargement in Colorectal Cancer
|
||
Completed |
NCT03507699 -
Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
|
Phase 1 | |
Recruiting |
NCT05138094 -
LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection
|
N/A | |
Recruiting |
NCT03191110 -
The COLON Study: Colorectal Cancer Cohort
|